36747148|t|There is no evidence that carbon dioxide-enriched oxygen before apnea affects the time to arterial desaturation, but it might improve cerebral oxygenation in anesthetized obese patients: a single-blinded randomized crossover trial.
36747148|a|PURPOSE: Carbon dioxide (CO2) increases cerebral perfusion. The effect of CO2 on apnea tolerance, such as after anesthesia induction, is unknown. This study aimed to assess if cerebral apnea tolerance can be improved in obese patients under general anesthesia when comparing O2/Air (95%O2) to O2/CO2 (95%O2/5%CO2). METHODS: In this single-center, single-blinded, randomized crossover trial, 30 patients 18-65 years, with body mass index > 35 kg/m2, requiring general anesthesia for bariatric surgery, underwent two apneas that were preceded by ventilation with either O2/Air or O2/CO2 in random order. After anesthesia induction, intubation, and ventilation with O2/Air or O2/CO2 for 10 min, apnea was performed until the cerebral tissue oxygenation index (TOI) dropped by a relative 20% from baseline (primary endpoint) or oxygen saturation (SpO2) reached 80% (safety abortion criterion). The intervention was then repeated with the second substance. RESULTS: The safety criterion was reached in all patients before cerebral TOI decreased by 20%. The time until SpO2 dropped to 80% was similar in the two groups (+ 6 s with O2/CO2, 95%CI -7 to 19 s, p = 0.37). Cerebral TOI and PaO2 were higher after O2/CO2 (+ 1.5%; 95%CI: from 0.3 to 2.6; p = 0.02 and + 0.6 kPa; 95%CI: 0.1 to 1.1; p = 0.02). CONCLUSION: O2/CO2 improves cerebral TOI and PaO2 in anesthetized bariatric patients. Better apnea tolerance could not be confirmed.
36747148	26	40	carbon dioxide	Chemical	MESH:D002245
36747148	50	56	oxygen	Chemical	MESH:D010100
36747148	64	69	apnea	Disease	MESH:D001049
36747148	99	111	desaturation	Disease	
36747148	171	176	obese	Disease	MESH:D009765
36747148	177	185	patients	Species	9606
36747148	241	255	Carbon dioxide	Chemical	MESH:D002245
36747148	257	260	CO2	Chemical	MESH:D002245
36747148	306	309	CO2	Chemical	MESH:D002245
36747148	313	318	apnea	Disease	MESH:D001049
36747148	408	422	cerebral apnea	Disease	MESH:D001049
36747148	452	457	obese	Disease	MESH:D009765
36747148	458	466	patients	Species	9606
36747148	507	509	O2	Chemical	MESH:D010100
36747148	518	520	O2	Chemical	MESH:D010100
36747148	525	527	O2	Chemical	MESH:D010100
36747148	528	531	CO2	Chemical	MESH:D002245
36747148	536	538	O2	Chemical	MESH:D010100
36747148	541	544	CO2	Chemical	MESH:D002245
36747148	626	634	patients	Species	9606
36747148	747	753	apneas	Disease	MESH:D001049
36747148	800	802	O2	Chemical	MESH:D010100
36747148	810	812	O2	Chemical	MESH:D010100
36747148	813	816	CO2	Chemical	MESH:D002245
36747148	895	897	O2	Chemical	MESH:D010100
36747148	905	907	O2	Chemical	MESH:D010100
36747148	908	911	CO2	Chemical	MESH:D002245
36747148	924	929	apnea	Disease	MESH:D001049
36747148	1056	1062	oxygen	Chemical	MESH:D010100
36747148	1233	1241	patients	Species	9606
36747148	1357	1359	O2	Chemical	MESH:D010100
36747148	1360	1363	CO2	Chemical	MESH:D002245
36747148	1434	1436	O2	Chemical	MESH:D010100
36747148	1437	1440	CO2	Chemical	MESH:D002245
36747148	1540	1542	O2	Chemical	MESH:D010100
36747148	1543	1546	CO2	Chemical	MESH:D002245
36747148	1604	1612	patients	Species	9606
36747148	1621	1626	apnea	Disease	MESH:D001049
36747148	Negative_Correlation	MESH:D002245	MESH:D001049
36747148	Negative_Correlation	MESH:D002245	MESH:D009765
36747148	Negative_Correlation	MESH:D010100	MESH:D001049
36747148	Negative_Correlation	MESH:D010100	MESH:D009765
36747148	Cotreatment	MESH:D002245	MESH:D010100

